A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials